TRODELVY 180 mg/1
SACITUZUMAB GOVITECAN · POWDER, FOR SOLUTION · Gilead Sciences, Inc.
TRODELVY is a powder, for solution containing sacituzumab govitecan at 180 mg/1, taken intravenous. Manufactured by Gilead Sciences, Inc..
Key Facts
- Brand Name
- TRODELVY
- Generic Name
- SACITUZUMAB GOVITECAN
- NDC Code (Product)
55135-132- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 180 mg/1
- Dosage Form
- POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761115
- Marketing Start
- 04/22/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is TRODELVY used for?
TRODELVY contains SACITUZUMAB GOVITECAN. It is a powder, for solution taken intravenous. Consult your doctor for specific uses.
Is TRODELVY a controlled substance?
TRODELVY is not classified as a controlled substance by the DEA.
What is the generic name for TRODELVY?
The generic name for TRODELVY is SACITUZUMAB GOVITECAN. There are no other listed brand versions of SACITUZUMAB GOVITECAN.
What is the NDC code for TRODELVY 180 mg/1?
The NDC (National Drug Code) for TRODELVY 180 mg/1 is 55135-132, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)